Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist

摘要

The present invention relates to the treatment of hypertension and type 2 diabetes, Metabolic Syndrome or a pre-diabetic state, by the administration of a therapeutically effective amount of a combination of a dual PPARalpha/gamma agonist and an Angiotensin II type I receptor antagonist, including pharmaceutically acceptable salts and solvates of said active ingredients.